227 related articles for article (PubMed ID: 21499427)
1. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles.
Rodríguez-Luccioni HL; Latorre-Esteves M; Méndez-Vega J; Soto O; Rodríguez AR; Rinaldi C; Torres-Lugo M
Int J Nanomedicine; 2011; 6():373-80. PubMed ID: 21499427
[TBL] [Abstract][Full Text] [Related]
2. Magnetic fluid hyperthermia enhances cytotoxicity of bortezomib in sensitive and resistant cancer cell lines.
Alvarez-Berríos MP; Castillo A; Rinaldi C; Torres-Lugo M
Int J Nanomedicine; 2014; 9():145-53. PubMed ID: 24379665
[TBL] [Abstract][Full Text] [Related]
3. Enhanced proteotoxic stress: one of the contributors for hyperthermic potentiation of the proteasome inhibitor bortezomib using magnetic nanoparticles.
Alvarez-Berrios MP; Castillo A; Merida F; Mendez J; Rinaldi C; Torres-Lugo M
Biomater Sci; 2015 Feb; 3(2):391-400. PubMed ID: 26218130
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
[TBL] [Abstract][Full Text] [Related]
5. Hyperthermia induced by magnetic nanoparticles improves the effectiveness of the anticancer drug cis-diamminedichloroplatinum.
Lee JS; Rodríguez-Luccioni HL; Méndez J; Sood AK; Lpez-Berestein G; Rinaldi C; Torres-Lugo M
J Nanosci Nanotechnol; 2011 May; 11(5):4153-7. PubMed ID: 21780419
[TBL] [Abstract][Full Text] [Related]
6. Magnetic hyperthermia enhances cell toxicity with respect to exogenous heating.
Sanz B; Calatayud MP; Torres TE; Fanarraga ML; Ibarra MR; Goya GF
Biomaterials; 2017 Jan; 114():62-70. PubMed ID: 27846403
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermic potentiation of cisplatin by magnetic nanoparticle heaters is correlated with an increase in cell membrane fluidity.
Alvarez-Berríos MP; Castillo A; Mendéz J; Soto O; Rinaldi C; Torres-Lugo M
Int J Nanomedicine; 2013; 8():1003-13. PubMed ID: 23493492
[TBL] [Abstract][Full Text] [Related]
8. Application of biocompatible and ultrastable superparamagnetic iron(III) oxide nanoparticles doped with magnesium for efficient magnetic fluid hyperthermia in lung cancer cells.
Nowicka AM; Ruzycka-Ayoush M; Kasprzak A; Kowalczyk A; Bamburowicz-Klimkowska M; Sikorska M; Sobczak K; Donten M; Ruszczynska A; Nowakowska J; Grudzinski IP
J Mater Chem B; 2023 May; 11(18):4028-4041. PubMed ID: 36960952
[TBL] [Abstract][Full Text] [Related]
9. Application of magnetic field hyperthermia and superparamagnetic iron oxide nanoparticles to HIV-1-specific T-cell cytotoxicity.
Williams JP; Southern P; Lissina A; Christian HC; Sewell AK; Phillips R; Pankhurst Q; Frater J
Int J Nanomedicine; 2013; 8():2543-54. PubMed ID: 23901272
[TBL] [Abstract][Full Text] [Related]
10. Shape-controlled fabrication of magnetite silver hybrid nanoparticles with high performance magnetic hyperthermia.
Ding Q; Liu D; Guo D; Yang F; Pang X; Che R; Zhou N; Xie J; Sun J; Huang Z; Gu N
Biomaterials; 2017 Apr; 124():35-46. PubMed ID: 28187393
[TBL] [Abstract][Full Text] [Related]
11. Dual pH and temperature stimuli-responsive magnetic nanohydrogels for thermo-chemotherapy.
Jaiswal MK; Pradhan A; Banerjee R; Bahadur D
J Nanosci Nanotechnol; 2014 Jun; 14(6):4082-9. PubMed ID: 24738355
[TBL] [Abstract][Full Text] [Related]
12. Applications of magnetic nanoparticles in medicine: magnetic fluid hyperthermia.
Latorre M; Rinaldi C
P R Health Sci J; 2009 Sep; 28(3):227-38. PubMed ID: 19715115
[TBL] [Abstract][Full Text] [Related]
13. In vitro Ultrasonic Potentiation of 2-Phenylethynesulfonamide/Magnetic Fluid Hyperthermia Combination Treatments for Ovarian Cancer.
Mérida F; Rinaldi C; Juan EJ; Torres-Lugo M
Int J Nanomedicine; 2020; 15():419-432. PubMed ID: 32021188
[TBL] [Abstract][Full Text] [Related]
14. Combining Bulk Temperature and Nanoheating Enables Advanced Magnetic Fluid Hyperthermia Efficacy on Pancreatic Tumor Cells.
Engelmann UM; Roeth AA; Eberbeck D; Buhl EM; Neumann UP; Schmitz-Rode T; Slabu I
Sci Rep; 2018 Sep; 8(1):13210. PubMed ID: 30181576
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic mechanism of treating SMMC-7721 liver cancer cells with magnetic fluid hyperthermia using Fe₂O₃ nanoparticles.
Yan SY; Chen MM; Fan JG; Wang YQ; Du YQ; Hu Y; Xu LM
Braz J Med Biol Res; 2014 Nov; 47(11):947-59. PubMed ID: 25296356
[TBL] [Abstract][Full Text] [Related]
16. The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels.
Franke K; Kettering M; Lange K; Kaiser WA; Hilger I
Int J Nanomedicine; 2013; 8():351-63. PubMed ID: 23378758
[TBL] [Abstract][Full Text] [Related]
17. Development and Assessment of Nano-Technologies for Cancer Treatment: Cytotoxicity and Hyperthermia Laboratory Studies.
Medina-Ramírez IE; Díaz de León Olmos MA; Muñoz Ortega MH; Zapien JA; Betancourt I; Santoyo-Elvira N
Cancer Invest; 2020 Jan; 38(1):61-84. PubMed ID: 31791151
[TBL] [Abstract][Full Text] [Related]
18. In vitro anti-cancer efficacy of multi-functionalized magnetite nanoparticles combining alternating magnetic hyperthermia in glioblastoma cancer cells.
Minaei SE; Khoei S; Khoee S; Vafashoar F; Mahabadi VP
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():575-587. PubMed ID: 31029351
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in nanosized Mn-Zn ferrite magnetic fluid hyperthermia for cancer treatment.
Lin M; Huang J; Sha M
J Nanosci Nanotechnol; 2014 Jan; 14(1):792-802. PubMed ID: 24730298
[TBL] [Abstract][Full Text] [Related]
20. Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids.
Palzer J; Mues B; Goerg R; Aberle M; Rensen SS; Olde Damink SWM; Vaes RDW; Cramer T; Schmitz-Rode T; Neumann UP; Slabu I; Roeth AA
Int J Nanomedicine; 2021; 16():2965-2981. PubMed ID: 33935496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
